Corline Biomedical AB (STO:CLBIO)

Sweden · Delayed Price · Currency is SEK

18.20

-0.25 (-1.36%)

Aug 13, 2026, 5:09 PM CET

Corline Biomedical AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-14.18	-14.75	-23.17	-1.79	2.33	-6.91
Depreciation & Amortization	0.1	0.1	0.1	0.1	0.06	0.03
Other Adjustments	0.04	0.04	9.96	-0.02	-	-0.01
Change in Receivables	-3.01	-0.05	3.41	3	-6.6	-1.13
Changes in Inventories	-0.82	-	-	-	-	-
Changes in Accounts Payable	-0.66	-2.16	1.12	-2.37	2.38	0.52
Changes in Accrued Expenses	1.03	-0.87	-0.06	1.97	-4.62	2.67
Operating Cash Flow	-17.51	-17.69	-8.64	0.89	-6.45	-4.84
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-0.4	-0.05	-	-0.13	-0.15	-0.14
Purchases of Intangible Assets	-0.8	-0.94	-7.5	-10.49	-8.85	-9.48
Purchases of Investments	0	0	-	-	0	0.06
Investing Cash Flow	-1.2	-0.98	-7.5	-10.62	-9	-9.56

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Long-Term Debt Issued	9.13	-	-	-	-	-
Net Long-Term Debt Issued (Repaid)	9.13	-	-	-	-	-
Issuance of Common Stock	32.21	23.02	16.79	0.54	0.03	50.63
Net Common Stock Issued (Repurchased)	32.21	23.02	16.79	0.54	0.03	50.63
Other Financing Activities	-	-1.46	-	-	0	-3.51
Financing Cash Flow	39.88	21.56	16.79	0.54	0.03	47.13

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash Flow	21.17	2.89	0.66	-9.2	-15.43	32.73

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-17.91	-17.74	-8.64	0.75	-6.61	-4.98
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	-167.46%	-205.78%	-48.85%	2.10%	-19.82%	-28.82%
Free Cash Flow Per Share	-0.72	-0.72	-0.40	0.04	-0.30	-0.24
Levered Free Cash Flow	-5.77	-17.69	-22.04	-2.25	-0	-3.84
Unlevered Free Cash Flow	-14.94	-17.72	-22.01	-2.23	-0	-3.83